709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors
| Published in: | Journal for ImmunoTherapy of Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| _version_ | 1851883577733545984 |
|---|---|
| author | Yun Wang Ribhu Nayar Mollie Jurewicz Qikai Xu Yifan Wang Nancy Nabilsi Gavin MacBeath Marlyane Motta Jim Murray Debora Barton Jenny Tadros Badr Kiaf Victor Ospina Alok Das Mahopatra Tary Traore Antoine J Boudot Cagan Gurer Shrikanta Chattopadhyay Hannah Bader Chris Malcuit Andrew Ferretti Zhonghua Zhu Krista Daniels Briana Zimmerman Amanda Kordosky Ray Lockard |
| author_facet | Yun Wang Ribhu Nayar Mollie Jurewicz Qikai Xu Yifan Wang Nancy Nabilsi Gavin MacBeath Marlyane Motta Jim Murray Debora Barton Jenny Tadros Badr Kiaf Victor Ospina Alok Das Mahopatra Tary Traore Antoine J Boudot Cagan Gurer Shrikanta Chattopadhyay Hannah Bader Chris Malcuit Andrew Ferretti Zhonghua Zhu Krista Daniels Briana Zimmerman Amanda Kordosky Ray Lockard |
| author_sort | Yun Wang |
| collection | DOAJ |
| container_title | Journal for ImmunoTherapy of Cancer |
| format | Article |
| id | doaj-art-8f9a46acdb034c0983a0a3eed0d03d8c |
| institution | Directory of Open Access Journals |
| issn | 2051-1426 |
| language | English |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| spelling | doaj-art-8f9a46acdb034c0983a0a3eed0d03d8c2025-08-19T22:12:14ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0709709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumorsYun Wang0Ribhu Nayar1Mollie Jurewicz2Qikai Xu3Yifan Wang4Nancy Nabilsi5Gavin MacBeath6Marlyane Motta7Jim Murray8Debora Barton9Jenny Tadros10Badr Kiaf11Victor Ospina12Alok Das Mahopatra13Tary Traore14Antoine J Boudot15Cagan Gurer16Shrikanta Chattopadhyay17Hannah Bader18Chris Malcuit19Andrew Ferretti20Zhonghua Zhu21Krista Daniels22Briana Zimmerman23Amanda Kordosky24Ray Lockard25Department of Anesthesiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, ChinaTScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USA1TScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USA3Repertoire Immune Medicines, Cambridge, MA, USA5TScan Therapeutics, Waltham, MA, USA1TScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USA1TScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USA5TScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USATScan Therapeutics, Waltham, MA, USA1TScan Therapeutics, Waltham, MA, USA1TScan Therapeutics, Waltham, MA, USA1TScan Therapeutics, Waltham, MA, USA1TScan Therapeutics, Waltham, MA, USA1TScan Therapeutics, Waltham, MA, USA1TScan Therapeutics, Waltham, MA, USA |
| spellingShingle | Yun Wang Ribhu Nayar Mollie Jurewicz Qikai Xu Yifan Wang Nancy Nabilsi Gavin MacBeath Marlyane Motta Jim Murray Debora Barton Jenny Tadros Badr Kiaf Victor Ospina Alok Das Mahopatra Tary Traore Antoine J Boudot Cagan Gurer Shrikanta Chattopadhyay Hannah Bader Chris Malcuit Andrew Ferretti Zhonghua Zhu Krista Daniels Briana Zimmerman Amanda Kordosky Ray Lockard 709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors |
| title | 709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors |
| title_full | 709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors |
| title_fullStr | 709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors |
| title_full_unstemmed | 709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors |
| title_short | 709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors |
| title_sort | 709 trial in progress product characteristics and clinical trial design for t plex a multiplexed enhanced t cell receptor engineered t cell therapy for solid tumors |
| work_keys_str_mv | AT yunwang 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT ribhunayar 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT molliejurewicz 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT qikaixu 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT yifanwang 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT nancynabilsi 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT gavinmacbeath 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT marlyanemotta 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT jimmurray 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT deborabarton 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT jennytadros 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT badrkiaf 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT victorospina 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT alokdasmahopatra 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT tarytraore 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT antoinejboudot 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT cagangurer 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT shrikantachattopadhyay 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT hannahbader 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT chrismalcuit 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT andrewferretti 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT zhonghuazhu 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT kristadaniels 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT brianazimmerman 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT amandakordosky 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors AT raylockard 709trialinprogressproductcharacteristicsandclinicaltrialdesignfortplexamultiplexedenhancedtcellreceptorengineeredtcelltherapyforsolidtumors |